| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/03/2009 | US7485634 Methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of |
| 02/03/2009 | US7485626 Biosynthesis of Dna ; cell proliferation; overlapping enzyme activation ; mixture of proteolytic enzyme and dipeptidyl peptidase inhibitors; autoimmune disease; antiinflammatory agents graft versus host diease |
| 02/03/2009 | US7485620 Use in the control of glycemia in aging patients, GH deficient patients, diabetic patients and obese patients |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |
| 02/03/2009 | US7485290 bacteria belongs to the genus Megasphaera or Mitsuokella |
| 02/03/2009 | CA2538905C Withanamide glycoside and compositions and methods of use thereof |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2412055C Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 02/03/2009 | CA2185565C Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/29/2009 | WO2009014674A1 Heterocyclylamides as gut microsomal triglyceride transport protein inhibitors |
| 01/29/2009 | WO2009014471A2 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
| 01/29/2009 | WO2009014411A1 Drug that can reduce cholesterol and urea levels and stabilise glucose, creatinine and triglyceride levels, prepared from eisenia foetida |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |
| 01/29/2009 | WO2009013885A1 Inhibitor of the differentiation of t cells into th1 cells |
| 01/29/2009 | WO2009013794A1 INSULIN SECRETION INDUCER, AND ACCELERATOR OF INCREASE IN PANCREATIC β-CELLS |
| 01/29/2009 | WO2009013357A1 Use of yeast flakes for treating and/or preventing hyperinsulinemia |
| 01/29/2009 | WO2009013195A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| 01/29/2009 | WO2009013010A2 5ht6-ligands such as sulfonamide derivatives in drug- induced weight-gain |
| 01/29/2009 | WO2009012650A1 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
| 01/29/2009 | WO2009012647A1 Preparation methods of quinazoline derivatives and their pharmaceutical uses |
| 01/29/2009 | WO2009012573A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/29/2009 | WO2008150074A3 The composition comprising the extracts, fractions and the isolated compounds of rhus verniciflua for prevention and treatment of diabetic complications |
| 01/29/2009 | WO2008149177A3 Marine lipid compositions and uses thereof |
| 01/29/2009 | WO2008114089A3 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 01/29/2009 | WO2008085921A3 Methods for reduction of adipose tissue mass |
| 01/29/2009 | WO2008059372A3 Crystal form of (3r,5r)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-metyl-benzylcarbamoyl)-2h-pyrazol-3-yl]-3,5-dihydroxy-heptanoic acid sodium salt |
| 01/29/2009 | WO2007061661A4 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/29/2009 | US20090030081 Use of lr-90 and lr-102 to overcome insulin resistance |
| 01/29/2009 | US20090030080 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 01/29/2009 | US20090030077 Novel Fenofibrate Formulations and Related Methods of Treatment |
| 01/29/2009 | US20090030063 Combined pharmaceutical preparation for treatment of type 2 diabetes |
| 01/29/2009 | US20090030050 Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use |
| 01/29/2009 | US20090030046 N-[3-[(2S)-1-methoxypropan-2-yl]oxy-5-(4-methylsulfonylphenoxy)phenyl]-1H-imidazole-5-carboxamide, used as antidiabetic agents, especially for the treatment of non-insulin dependent diabetes |
| 01/29/2009 | US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor |
| 01/29/2009 | US20090030023 Pyrimidine compounds and medicinal composition thereof |
| 01/29/2009 | US20090030013 Substituted tetrahydro-quinoline-sulfonamide compounds, their preparation and use as medicaments |
| 01/29/2009 | US20090030011 1-Aminocarbonyl-, 1-aminosulfoxyl- and 1-aminosulfonyl-substituted triazolopyridines, e.g., 5-chloro-[1,2,3]triazolo[4,5-b]pyridin-1-yl)-(3,4-dihydro-1H-isoquinolin-2-yl)-methanone; these compounds lower triglyceride levels and are used to prevent and treat type II diabetes and arteriosclerosis |
| 01/29/2009 | US20090030008 Piperazine derivatives and their use as therapeutic agents |
| 01/29/2009 | US20090030006 sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor; 1,1-anhydro-1-C-[5-(4-ethylphenyl)methyl-2-(hydroxymethyl)phenyl]- beta -D-glucopyranose, for example |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029978 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 01/29/2009 | US20090029969 1-(2,4-dichlorophenyl)-4-methyl-5-(5-(pent-1-enyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide; cannabinoid receptor modulator; liver fibrosis, obesity, type II diabetes, atherosclerosis, analgesia, haemorrhagic shock, ischemia, liver cirrhosis, neurodegenerative diseases |
| 01/29/2009 | US20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 01/29/2009 | US20090029942 Administration of copper to an animal |
| 01/29/2009 | US20090029933 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 01/29/2009 | US20090029927 Compounds having inhibitory activity against sodium-dependent glucose transporter |
| 01/29/2009 | US20090029923 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 01/29/2009 | US20090029913 Novel exendin agonist compounds |
| 01/29/2009 | US20090029910 Combinations of somatostatin-analogs with different selectivity for human somatostatin receptor subtypes |
| 01/29/2009 | US20090029905 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/29/2009 | US20090029904 Compositions and methods for treatment of insulin-resistance diseases |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090029400 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/29/2009 | US20090028945 Immunoisolative encapsulation system |
| 01/29/2009 | US20090028939 Solid Preparation |
| 01/29/2009 | US20090028896 Compositions and method for weight loss |
| 01/29/2009 | US20090028882 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | DE102007035367A1 Substituierte Aryloxazole und ihre Verwendung Substituted Aryloxazole and their use |
| 01/29/2009 | DE102007035334A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments |
| 01/29/2009 | DE102007035333A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments |
| 01/29/2009 | CA2696462A1 use of yeast flakes for treating and/or preventing hyperinsulinemia |
| 01/29/2009 | CA2694222A1 Insulin secretion inducer, and accelerator for increasing the number of pancreatic .beta.-cells |
| 01/29/2009 | CA2693377A1 5-pyridinone substituted indazoles |
| 01/29/2009 | CA2693290A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/29/2009 | CA2693207A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators |
| 01/29/2009 | CA2693169A1 N-linked heterocyclic receptor agonists for the treatment of metabolic disorders |
| 01/28/2009 | EP2019100A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 01/28/2009 | EP2019099A1 Dpp-IV inhibitors |
| 01/28/2009 | EP2019098A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 01/28/2009 | EP2018871A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 01/28/2009 | EP2018863A1 Fused heterocyclic compound and use thereof |
| 01/28/2009 | EP2018861A1 5HT6-Ligands such as sulfonamide derivatives in drug-induced weight-gain |
| 01/28/2009 | EP2018853A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 01/28/2009 | EP2018376A1 Benzylamine derivatives as cetp inhibitors |
| 01/28/2009 | EP2018185A1 Use of mas-g-protein-coupled receptor agonists in the treatment of the metabolic syndrome, its components and its complications |
| 01/28/2009 | EP1541672B1 Composition for promoting the proliferation of lactobacillus casei subsp. casei |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356155A Phenoxy acetic acids as PPAR-delta activators |
| 01/28/2009 | CN101355954A Therapeutic agent for metabolic syndrome and food containingthe therapeutic agent |
| 01/28/2009 | CN101355949A Combination of triazine derivatives and insulin secretion stimulators |
| 01/28/2009 | CN101355938A Pharmaceutical use of substituted amides |
| 01/28/2009 | CN101353663A Anti-I type diabetes fuse protein and preparation thereof |
| 01/28/2009 | CN101352539A Composite of Chinese traditional medicine for diabetes mellitus |
| 01/28/2009 | CN101352519A Chinese herbal medicine composition for treating diabetics |
| 01/28/2009 | CN101352512A Chinese medicine composition for treating diabetes and method for preparing the same |
| 01/28/2009 | CN101352498A Formulation for reducing medicine toxicity damage and improving immunity and regulating blood sugar and preparation method thereof |
| 01/28/2009 | CN101352492A Medicament composition for treating cardio-cerebrovascular disease and regulating blood fat |
| 01/28/2009 | CN101352487A Long pepper extract, preparation method thereof, medicament composition and uses thereof |
| 01/28/2009 | CN101352483A Medicine for treating diabetes |
| 01/28/2009 | CN101352475A Use of honeysuckle aqueous extract in preparing medicament for improving insulin resistance |
| 01/28/2009 | CN101352474A Uses of prickly pear and prickly pear polysaccharide in preparing medicament or health products |
| 01/28/2009 | CN101352473A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352472A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352471A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352470A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352469A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352461A Novel use of extract of Acer truncatum leaves |